Benzethonium Chloride Review Urged By Lonza Before Final Monograph
This article was originally published in The Rose Sheet
Executive Summary
FDA should complete a safety review of benzethonium chloride as a Category I active ingredient for the healthcare antiseptic products monograph before finalizing the rule, chemical ingredient supplier Lonza says in a recent letter to the agency.